Business Segments · Revenue

Consumer Tissue — Revenue

Kimberly-Clark Consumer Tissue — Revenue increased by 3.6% to $1.54B in Q3 2024 compared to the prior quarter. Year-over-year, this metric declined by 1.8%, from $1.57B to $1.54B. Over 2 years (FY 2021 to FY 2023), Consumer Tissue — Revenue shows relatively stable performance with a 2.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ2 2015
Last reportedQ4 2025
Rolls up toTotal Revenue

How to read this metric

Growth indicates strong demand, effective pricing, or market share gains in the tissue category.

Detailed definition

The total gross sales generated by the Consumer Tissue segment, representing the primary top-line performance indicator...

Peer comparison

Standard revenue metric for business segments across all consumer goods manufacturers.

Metric ID: kmb_segment_consumer_tissue_revenues

Historical Data

14 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24
Value$1.42B$1.54B$1.56B$1.57B$1.54B$1.58B$1.56B$1.63B$1.55B$1.57B$1.54B$1.60B$1.49B$1.54B
QoQ Change+8.2%+1.2%+0.6%-2.0%+2.7%-1.1%+4.7%-5.2%+1.2%-1.7%+3.8%-7.1%+3.6%
YoY Change+7.9%+2.4%+0.1%+4.2%+0.8%-0.7%-1.3%-2.1%-4.1%-1.8%
Range$1.42B$1.63B
CAGR+2.4%
Avg YoY Growth+0.5%
Median YoY Growth-0.3%

Frequently Asked Questions

What is Kimberly-Clark's consumer tissue — revenue?
Kimberly-Clark (KMB) reported consumer tissue — revenue of $1.54B in Q3 2024.
How has Kimberly-Clark's consumer tissue — revenue changed year-over-year?
Kimberly-Clark's consumer tissue — revenue decreased by 1.8% year-over-year, from $1.57B to $1.54B.
What is the long-term trend for Kimberly-Clark's consumer tissue — revenue?
Over 2 years (2021 to 2023), Kimberly-Clark's consumer tissue — revenue has grown at a 2.1% compound annual growth rate (CAGR), from $6.03B to $6.29B.
What does consumer tissue — revenue mean?
Total sales revenue generated specifically by the Consumer Tissue business segment.